DCM

DAFNA Capital Management Portfolio holdings

AUM $405M
1-Year Est. Return 24.52%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+24.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$99.1M
AUM Growth
-$6.37M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
65
New
Increased
Reduced
Closed

Top Buys

1
+$3.9M
2
+$3.01M
3
+$2.52M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$1.67M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$1.04M

Top Sells

1
+$4.42M
2
+$2.08M
3
+$1.47M
4
KERX
Keryx Biopharmaceuticals Inc
KERX
+$1.42M
5
GLMD icon
Galmed Pharmaceuticals
GLMD
+$766K

Sector Composition

1 Healthcare 55.76%
2 Financials 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$911K 0.92%
90,947
27
$897K 0.9%
+1,930
28
$896K 0.9%
88,694
29
$756K 0.76%
+12,000
30
$747K 0.75%
+76,400
31
$724K 0.73%
31,636
32
$681K 0.69%
+238,900
33
$572K 0.58%
37,500
34
$530K 0.53%
500
-4,170
35
$525K 0.53%
+75,000
36
$473K 0.48%
2,000
37
$413K 0.42%
+35,829
38
$411K 0.41%
2,864
-2,705
39
$387K 0.39%
75,930
40
$372K 0.38%
17,500
41
$370K 0.37%
5,000
42
$362K 0.37%
1,335
-29
43
$339K 0.34%
+170
44
$296K 0.3%
+32,000
45
$268K 0.27%
220
46
$259K 0.26%
+26,000
47
$259K 0.26%
29,018
+19,540
48
$244K 0.25%
116,279
49
$219K 0.22%
+7,279
50
$212K 0.21%
1,500
1
2
3